Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1517/14656566.2016.1157580 http://scihub22266oqcxt.onion/10.1517/14656566.2016.1157580 C4930150!4930150!26898158     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Expert+Opin+Pharmacother 2016 ; 17 (5): 743-9 Nephropedia Template TP {{tp|p=26898158|t=2016. Sofosbuvir and Ledipasvir for HIV/HCV Co-infected Patients |pdf=|usr=}}{{26898158}} gab.com Text Sofosbuvir and Ledipasvir for HIV/HCV Co-infected Patients JO: Expert Opin Pharmacother http://www.kidney.de/pget.php?&tw=1&pmid=26898158 #FOAvip Introduction: Hepatitis C virus (HCV) is a chronic infection that disproportionately impacts people living with HIV. In the past, HCV therapy was less effective in individuals with HIV co-infection. However, the advent of direct-acting antivirals has revolutionized HCV treatment with high rates of success in patients both with and without HIV. Areas covered: In this paper, we review the evidence supporting the use of ledipasvir and sofosbuvir (LDV/SOF) for the treatment of HCV in patients with HIV co-infection. Articles searchable on MEDLINE/PubMed were reviewed to provide context for use of LDV/SOF in individuals with HCV and HIV co-infection. Expert opinion: This treatment is highly effective in achieving HCV cure or sustained virologic response, however further studies need to done to address efficacy of treatment in people with uncontrolled HIV, concerns regarding drug-interactions with antiretroviral therapy, and potential for shorter duration treatment. Twit Text FOAVip Sofosbuvir and Ledipasvir for HIV/HCV Co-infected Patients ????Expert Opin Pharmacother http://www.kidney.de/pget.php?&tw=1&pmid=26898158 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26898158 #FOAvip English Wikipedia <ref>{{Cite pmid|26898158}}</ref> Sofosbuvir and Ledipasvir for HIV/HCV Co-infected Patients #MMPMID26898158 Rosenthal ES; Kottilil S; Polis MA Expert Opin Pharmacother 2016[Apr]; 17 (5): 743-9 PMID26898158show ga Introduction: Hepatitis C virus (HCV) is a chronic infection that disproportionately impacts people living with HIV. In the past, HCV therapy was less effective in individuals with HIV co-infection. However, the advent of direct-acting antivirals has revolutionized HCV treatment with high rates of success in patients both with and without HIV. Areas covered: In this paper, we review the evidence supporting the use of ledipasvir and sofosbuvir (LDV/SOF) for the treatment of HCV in patients with HIV co-infection. Articles searchable on MEDLINE/PubMed were reviewed to provide context for use of LDV/SOF in individuals with HCV and HIV co-infection. Expert opinion: This treatment is highly effective in achieving HCV cure or sustained virologic response, however further studies need to done to address efficacy of treatment in people with uncontrolled HIV, concerns regarding drug-interactions with antiretroviral therapy, and potential for shorter duration treatment. äSofosbuvir and Ledipasvir for HIV/HCV Co-infected Patients (epmc).pdf DeepDyve Pubget Overpricing